Explore Our Biomarker Menu

Biomarker:

Glucagon

Biological or Clinical Significance:

Glucagon is a peptide hormone, produced by alpha cells of the pancreas Glucagon generally elevates the concentration of glucose in the blood by promoting gluconeogenesis and glycogenolysis. Its effect is opposite that of insulin, which lowers the glucose.

Glucagon binds to the glucagon receptor, a G protein-coupled receptor, located in the plasma membrane. The conformation change in the receptor activates G proteins, a heterotrimeric protein with α, β, and γ subunits. When the G protein interacts with the receptor, it undergoes a conformational change that results in the replacement of the GDP molecule that was bound to the α subunit with a GTP molecule. This substitution results in the releasing of the α subunit from the β and γ subunits. The alpha subunit specifically activates the next enzyme in the cascade, adenylate cyclase.

References:

Analyte:

Glucagon

Matrix:

Human K2 EDTA Plasma

Status:

Experienced Running

Sensitivity-LLOQ:

25 pg/mL

Sensitivity-ULOQ:

1,600 pg/mL

platform

MSD-ECL

Required Sample Volume

Disease State:

Metabolic

MSD Panel:

Speak To A Scientist





    I consent to receive communications (which may include, phone, email, social, and re-targeting ads) from BioAgilytix. I understand I may proactively manage my preferences or opt-out of communications with BioAgilytix at any time using the unsubscribe link provided in all of BioAgilytix’s email communications and can learn more by reading the privacy policy.

    Immunogenicity

    Learn why BioAgilytix is a world-leading authority on immunogenicity studies related to ADA, NAb assay development and validation, isotyping, and more.

    Case Studies

    Learn why we’re a trusted partner to 22 of the top 25 global pharma and biotech companies.